These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22671931)

  • 21. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
    Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
    Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility.
    Dalziel JE; Young W; Bercik P; Spencer NJ; Ryan LJ; Dunstan KE; Lloyd-West CM; Gopal PK; Haggarty NW; Roy NC
    Neurogastroenterol Motil; 2016 Aug; 28(8):1241-51. PubMed ID: 27028044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
    Gray AC; White PJ; Coupar IM
    Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice.
    Kimball ES; Palmer JM; D'Andrea MR; Hornby PJ; Wade PR
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1266-73. PubMed ID: 15691868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.
    Mori T; Shibasaki Y; Matsumoto K; Shibasaki M; Hasegawa M; Wang E; Masukawa D; Yoshizawa K; Horie S; Suzuki T
    J Pharmacol Exp Ther; 2013 Oct; 347(1):91-9. PubMed ID: 23902939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats.
    Dean RL; Eyerman D; Todtenkopf MS; Turncliff RZ; Bidlack JM; Deaver DR
    Pharmacol Biochem Behav; 2012 Jan; 100(3):530-7. PubMed ID: 22056608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.
    Shahbazian A; Heinemann A; Schmidhammer H; Beubler E; Holzer-Petsche U; Holzer P
    Br J Pharmacol; 2002 Feb; 135(3):741-50. PubMed ID: 11834622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of μ- and δ-Opioid Activities in Agents with Various κ-Receptor Selectivity.
    Grechko OY; Litvinov RA; Spasov AA; Rashchenko AI; Shtareva DM; Anisimova VA; Minkin VI
    Bull Exp Biol Med; 2017 Mar; 162(5):632-635. PubMed ID: 28361412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
    Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
    J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
    Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiate-induced constipation related to activation of small intestine opioid μ2-receptors.
    Chen W; Chung HH; Cheng JT
    World J Gastroenterol; 2012 Mar; 18(12):1391-6. PubMed ID: 22493554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial.
    Foxx-Orenstein AE; Camilleri M; Szarka LA; McKinzie S; Burton D; Thomforde G; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Oct; 19(10):821-30. PubMed ID: 17539894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.